Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- National University of Singapore
- Nature Careers
- ;
- AbbVie
- Harvard University
- Nanyang Technological University
- City of Hope
- DAAD
- RMIT UNIVERSITY
- RMIT University
- The University of Queensland
- University of British Columbia
- Indiana University
- Max Planck Institute for Biology of Ageing, Cologne
- Open Society Foundations
- Queen's University Belfast
- Villanova University
- Auburn University
- Australian National University
- Cold Spring Harbor Laboratory
- Curtin University
- Dana-Farber Cancer Institute
- Florida International University
- INESC TEC
- Johns Hopkins University
- King's College London
- La Trobe University
- Leibniz
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- QUEENS UNIVERSITY BELFAST
- Singapore Institute of Technology
- UNIVERSITY OF SURREY
- University of Adelaide
- University of Bergen
- University of Cambridge
- University of London
- University of New England
- University of Nottingham
- University of South-Eastern Norway
- Vanderbilt University
- Zukunftskolleg, University of Konstanz
- 31 more »
- « less
-
Field
-
treatments further adds to the already substantial impact on quality of life and underlines the need for improved knowledge on pathogenic mechanisms to inform novel drug targets for inflammatory skin diseases
-
. About you The post holder will have the following: Essential: Higher academic degree e.g. PhD, or evidence of an equivalent level of attainment in research publications A track record of scholarly
-
including in vivo and in vitro modeling, targeted and untargeted metabolomics, and stable isotope tracing to explore the role of mitochondrial transporters and enzyme systems in health and disease. Position
-
at conferences and seminars Stay current with relevant literature Your qualifications Strong track record of scientific accomplishments is essential Prior hands-on experience in cell culture, biochemical assays
-
focused on high throughput CRISPR screening to identify new cancer immunotherapy targets as part of an NHMRC Synergy Grant project titled “Improving outcomes for lung cancer patients: Discovering targetable
-
groundbreaking initiative to target cell surface proteins, which constitute nearly one-third of all coded proteins and are pivotal drug targets. While existing technologies, such as bifunctional degraders, have
-
planning and make such systems more reliable. BaneNOR are responsible for the Norwegian rail infrastructure and oversees operations, maintenance and construction of railways throughout the country
-
devices (LFDs) against clinically important targets. Prior research experience in developing LFDs is a mandatory requirement for this role. The complementary knowledge across nanotechnology, molecular
-
lateral flow devices (LFDs) against clinically important targets. Prior research experience in developing LFDs is a mandatory requirement for this role. The complementary knowledge across nanotechnology
-
healing. The Granville research program spans basic molecular biology and biochemistry through to target validation, proof-of-concept in animal and human models, and collaborations with clinicians and